Comparative proteomic analysis of rat aorta in a subtotal nephrectomy model

Proteomics

Volumn 10, Issue 13, 2010, Pages 2429-2443

  Lin, Yao Ping ^a,b   Hsu, Meng Erh ^b   Chiou, Yi Ying ^a   Hsu, Hung Yi ^b   Tsai, Hiao Chien ^b   Peng, Yu Ju ^b   Lu, Chi Yu ^c   Pan, Chien Yuan ^d   Yu, Wen Chung ^b   Chen, Chen Huan ^b   Chi, Chin Wen ^b   Lin, Chao Hsiung ^a,b,e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Animal proteomics; Aorta; Cardiovascular; Subtotal nephrectomy

Indexed keywords

CREATININE; ENALAPRIL; EPIDERMAL GROWTH FACTOR; HEAT SHOCK PROTEIN 27; MILK FAT GLOBULE EPIDERMAL GROWTH FACTOR 8; UNCLASSIFIED DRUG; UREA; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HSPB1 PROTEIN, RAT; MEMBRANE ANTIGEN; MFGE8 PROTEIN, RAT; MILK PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERIAL STIFFNESS; ARTICLE; BODY WEIGHT; CARDIOVASCULAR SYSTEM; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOSKELETON; DIASTOLIC BLOOD PRESSURE; DOWN REGULATION; EXPERIMENTAL MODEL; GLOMERULUS FILTRATION RATE; HEART RATE; HEART WEIGHT; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; MALE; NEPHRECTOMY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEOMICS; PULSE PRESSURE; PULSE WAVE; RAT; SYSTOLIC BLOOD PRESSURE; UPREGULATION; UREA BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; KIDNEY DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIGENS, SURFACE; AORTA; DISEASE MODELS, ANIMAL; ENALAPRIL; HSP27 HEAT-SHOCK PROTEINS; HUMANS; KIDNEY DISEASES; MALE; MILK PROTEINS; NEPHRECTOMY; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77954723318     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800658     Document Type: Article

References (73)

1. Levey, A. S., Atkins, R., Coresh, J., Cohen, E. P. et al., Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007, 72, 247-259.
2. Blacher, J., Guerin, A. P., Pannier, B., Marchais, S. J. et al., Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999, 99, 2434-2439.
3. London, G. M., Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin. Dial. 2003, 16, 85-94.
4. Guerin, A. P., Marchais, S. J., Metivier, F., London, G. M., Arterial structural and functional alterations in uraemia. Eur. J. Clin. Invest. 2005, 35, 85-88.
5. Lin, Y. P., Chen, C. H., Hsu, T. L., Yang, W. C., Ding, P. Y., Sequential tonometry as a practical method to estimate truncal pulse wave velocity. Zhonghua Yi. Xue. Za Zhi. (Taipei) 2001, 64, 693-702.
6. Lin, Y. P., Chen, C. H., Yu, W. C., Hsu, T. L. et al., Left ventricular mass and hemodynamic overload in normotensive hemodialysis patients. Kidney Int. 2002, 62, 1828-1838.
7. Lin, Y. P., Yu, W. C., Hsu, T. L., Ding, P. Y. et al., The extracellular fluid-to-intracellular fluid volume ratio is associated with large-artery structure and function in hemodialysis patients. Am. J. Kidney Dis. 2003, 42, 990-999.
8. Chen, C. H., Lin, Y. P., Yu, W. C., Yang, W. C., Ding, Y. A., Volume status and blood pressure during long-term hemodialysis: role of ventricular stiffness. Hypertension 2003, 42, 257-262.
9. Zoungas, S., Cameron, J. D., Kerr, P. G., Wolfe, R. et al., Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD. Am. J. Kidney Dis. 2007, 50, 622-630.
10. Mayr, M., Mayr, U., Chung, Y. L., Yin, X. et al., Vascular proteomics: linking proteomic and metabolomic changes. Proteomics 2004, 4, 3751-3761.
11. Mayr, U., Mayr, M., Yin, X., Begum, S. et al., Proteomic dataset of mouse aortic smooth muscle cells. Proteomics 2005, 5, 4546-4557. (Pubitemid 41739932)
12. Tseng, H. W., Juan, H. F., Huang, H. C., Lin, J. Y. et al., Lipopolysaccharide-stimulated responses in rat aortic endothelial cells by a systems biology approach. Proteomics 2006, 6, 5915-5928.
13. Dupont, A., Corseaux, D., Dekeyzer, O., Drobecq, H. et al., The proteome and secretome of human arterial smooth muscle cells. Proteomics 2005, 5, 585-596. (Pubitemid 40262075)
14. Bruneel, A., Labas, V., Mailloux, A., Sharma, S. et al., Proteomic study of human umbilical vein endothelial cells in culture. Proteomics 2003, 3, 714-723. (Pubitemid 36570261)
15. Yoshioka, T., Shiraga, H., Yoshida, Y., Fogo, A. et al., "Intact nephrons" as the primary origin of proteinuria in chronic renal disease Study in the rat model of subtotal nephrectomy. J. Clin. Invest. 1988, 82, 1614-1623.
16. Hughes, D. J., Babbs, C. F., Geddes, L. A., Bourland, J. D., Measurements of Young's modulus of elasticity of the canine aorta with ultrasound. Ultrason. Imaging 1979, 1, 356-367.
17. Wessel, D., Flugge, U. I., A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 1984, 138, 141-143.
18. Tatusov, R. L., Natale, D. A., Garkavtsev, I. V., Tatusova, T. A. et al., The COG database: new developments in phylogenetic classification of proteins from complete genomes. Nucleic Acids Res. 2001, 29, 22-28.
19. Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T. et al., A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation, Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 1999, 130, 461-470. (Pubitemid 29135798)
20. Perico, N., Benigni, A., Remuzzi, G., Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection. Nat. Rev. Drug Discov. 2008, 7, 936-953.
21. Mitchell, G. F., Increased aortic stiffness: an unfavorable cardiorenal connection. Hypertension 2004, 43, 151-153.
22. Nilsson, P. M., Boutouyrie, P., Laurent, S., Vascular aging: A tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension 2009, 54, 3-10.
23. Larsson, A., Peng, S., Persson, H., Rosenbloom, J. et al., Lactadherin binds to elastin--a starting point for medin amyloid formation? Amyloid 2006, 13, 78-85.
24. Fu, Z., Wang, M., Gucek, M., Zhang, J. et al., Milk fat globule protein epidermal growth factor-8: a pivotal relay element within the angiotensin II and monocyte chemoattractant protein-1 signaling cascade mediating vascular smooth muscle cells invasion. Circ. Res. 2009, 104, 1337-1346.
25. Shamaei-Tousi, A., Halcox, J. P., Henderson, B., Stressing? the obvious Cell stress and cell stress proteins in cardiovascular disease. Cardiovasc. Res. 2007, 74, 19-28.
26. Glembotski, C. C., Endoplasmic reticulum stress in the heart. Circ. Res. 2007, 101, 975-984.
27. Hedges, J. C., Dechert, M. A., Yamboliev, I. A., Martin, J. L. et al., A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration. J. Biol. Chem. 1999, 274, 24211-24219.
28. Kabakov, A. E., Budagova, K. R., Bryantsev, A. L., Latchman, D. S., Heat shock protein 70 or heat shock protein 27 overexpressed in human endothelial cells during posthypoxic reoxygenation can protect from delayed apoptosis. Cell Stress Chaperones 2003, 8, 335-347.
29. Arrigo, A. P., Virot, S., Chaufour, S., Firdaus,W. et al., Hsp27 consolidates intracellular redox homeostasis by upholding glutathione in its reduced form and by decreasing iron intracellular levels. Antioxid. Redox. Signal. 2005, 7, 414-422.
30. Hirano, S., Rees, R. S., Yancy, S. L., Welsh, M. J. et al., Endothelial barrier dysfunction caused by LPS correlates with phosphorylation of HSP27 in vivo. Cell Biol. Toxicol. 2004, 20, 1-14.
31. De, A. K., Kodys, K. M., Yeh, B. S., Miller-Graziano, C., Exaggerated human monocyte IL-10 concomitant to minimal TNF-alpha induction by heat-shock protein 27 (Hsp27) suggests Hsp27 is primarily an antiinflammatory stimulus. J. Immunol. 2000, 165, 3951-3958.
32. Martin-Ventura, J. L., Duran, M. C., Blanco-Colio, L. M., Meilhac, O. et al., Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation 2004, 110, 2216-2219. (Pubitemid 39372504)
33. Connolly, E. M., Kelly, C. J., Chen, G., O'Grady, T. et al., Pharmacological induction of HSP27 attenuates intimal hyperplasia in vivo. Eur. J. Vasc. Endovasc. Surg. 2003, 25, 40-47.
34. Intengan, H. D., Deng, L. Y., Li, J. S., Schiffrin, E. L., Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. Hypertension 1999, 33, 569-574. (Pubitemid 29065722)
35. Intengan, H. D., Thibault, G., Li, J. S., Schiffrin, E. L., Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation 1999, 100, 2267-2275.
36. Ge, G., Seo, N. S., Liang, X., Hopkins, D. R. et al., Bone morphogenetic protein-1/tolloid-related metalloproteinases process osteoglycin and enhance its ability to regulate collagen fibrillogenesis. J. Biol. Chem. 2004, 279, 41626-41633.
37. Takeda, U., Utani, A., Wu, J., Adachi, E. et al., Targeted disruption of dermatopontin causes abnormal collagen fibrillogenesis. J. Invest. Dermatol. 2002, 119, 678-683.
38. Durier, S., Fassot, C., Laurent, S., Boutouyrie, P. et al., Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness. Circulation 2003, 108, 1845-1851. (Pubitemid 37296094)
39. Masuda, H., Fukum oto, M., Hirayoshi, K., Nagata, K., Coexpression of the collagen-binding stress protein HSP47 gene and the alpha 1(I) and alpha 1(III) collagen genes in carbon tetrachloride-induced rat liver fibrosis. J. Clin. Invest 1994, 94, 2481-2488.
40. Sluijter, J. P., Smeets, M. B., Velema, E., Pasterkamp, G., de Kleijn, D. P., Increase in collagen turnover but not in collagen fiber content is associated with flow-induced arterial remodeling. J. Vasc. Res. 2004, 41, 546-555.
41. Sasaki, T., Takai, Y., The Rho small G protein family-Rho GDI system as a temporal and spatial determinant for cytoskeletal control. Biochem. Biophys. Res. Commun. 1998, 245, 641-645.
42. Bian, Y. L., Qi, Y. X., Yan, Z. Q., Long, D. K. et al., A proteomic analysis of aorta from spontaneously hypertensive rat: RhoGDI alpha upregulation by angiotensin II via AT(1) receptor. Eur. J. Cell Biol. 2008, 87, 101-110.
43. Zieman, S. J., Melenovsky, V., Kass, D. A., Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 932-943.
44. Pyle, W. G., La, R. G., de Tombe, P. P., Sumandea, M. P., Solaro, R. J., Control of cardiac myofilament activation and PKC-betaII signaling through the actin capping protein, CapZ. J. Mol. Cell Cardiol. 2006, 41, 537-543.
45. Scaffidi, P., Misteli, T., Lamin A-dependent nuclear defects in human aging. Science 2006, 312, 1059-1063.
46. Yuan, G., Hegele, R. A., Genetic forms of the cardiometabolic syndrome: what can they tell the clinician? J. Cardiometab. Syndr. 2007, 2, 45-48.
47. Candelario, J., Sudhakar, S., Navarro, S., Reddy, S., Comai, L., Perturbation of wild-type lamin Ametabolism results in a progeroid phenotype. Aging Cell 2008, 7, 355-367. (Pubitemid 351663904)
48. Azevedo, L. C., Pedro, M. A., Souza, L. C., de Souza, H. P. et al., Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. Cardiovasc. Res. 2000, 47, 436-445.
49. Collins, A. R., Lyon, C. J., Xia, X., Liu, J. Z. et al., Ageaccelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ. Res. 2009, 104, e42-e54.
50. Torzewski, M., Ochsenhirt, V., Kleschyov, A. L., Oelze, M. et al., Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 850-857.
51. Hayes, J. D., Strange, R. C., Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic. Res. 1995, 22, 193-207.
52. McBride, M. W., Brosnan, M. J., Mathers, J., McLellan, L. I. et al., Reduction of Gstm1 expression in the strokeprone spontaneously hypertension rat contributes to increased oxidative stress. Hypertension 2005, 45, 786-792.
53. Wenzel, P., Hink, U., Oelze, M., Schuppan, S. et al., Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity, Implications for mitochondrial oxidative stress and nitrate tolerance. J. Biol. Chem. 2007, 282, 792-799.
54. Wenzel, P., Muller, J., Zurmeyer, S., Schuhmacher, S. et al., ALDH-2 deficiency increases cardiovascular oxidative stress - evidence for indirect antioxidative properties. Biochem. Biophys. Res. Commun. 2008, 367, 137-143.
55. Narita, M., Kitagawa, K., Nagai, Y., Hougaku, H. et al., Effects of aldehyde dehydrogenase genotypes on carotid atherosclerosis. Ultrasound Med. Biol. 2003, 29, 1415-1419.
56. Maines, M. D., New insights into biliverdin reductase functions: linking heme metabolism to cell signaling. Physiology. (Bethesda) 2005, 20, 382-389.
57. Hopkins, P. N., Wu, L. L., Hunt, S. C., James, B. C. et al., Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 1996, 16, 250-255.
58. ndres-Mateos, E., Perier, C., Zhang, L., Blanchard-Fillion, B. et al., DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc. Natl. Acad. Sci. USA 2007, 104, 14807-14812.
59. Gupte, S. A., Arshad, M., Viola, S., Kaminski, P. M. et al., Pentose phosphate pathway coordinates multiple redoxcontrolled relaxing mechanisms in bovine coronary arteries. Am. J. Physiol. Heart Circ. Physiol. 2003, 285, H2316-H2326.
60. Matsui, R., Xu, S., Maitland, K. A., Mastroianni, R. et al., Glucose-6-phosphate dehydrogenase deficiency decreases vascular superoxide and atherosclerotic lesions in apolipoprotein E(-/-) mice. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 910-916.
61. Matsui, R., Xu, S., Maitland, K. A., Hayes, A. et al., Glucose-6 phosphate dehydrogenase deficiency decreases the vascular response to angiotensin II. Circulation 2005, 112, 257-263. (Pubitemid 40982309)
62. Rohra, D. K., Saito, S. Y., Ohizumi, Y., Functional role of Cl-channels in acidic pH-induced contraction of the aorta of spontaneously hypertensive and Wistar Kyoto rats. Eur. J. Pharmacol. 2002, 453, 279-286.
63. Mohammad-Panah, R., Harrison, R., Dhani, S., Ackerley, C. et al., The chloride channel ClC-4 contributes to endosomal acidification and trafficking. J. Biol. Chem. 2003, 278, 29267-29277.
64. Berg, J. T., Ramanathan, S., Gabrielli, M. G., Swenson, E. R., Carbonic anhydrase in mammalian vascular smooth muscle. J. Histochem. Cytochem. 2004, 52, 1101-1106.
65. Spicer, S. S., Lewis, S. E., Tashian, R. E., Schulte, B. A., Mice carrying a CAR-2 null allele lack carbonic anhydrase II immunohistochemically and show vascular calcification. Am. J. Pathol. 1989, 134, 947-954.
66. Mizobuchi, M., Towler, D., Slatopolsky, E., Vascular calcification: the killer of patients with chronic kidney disease. J. Am. Soc. Nephrol. 2009, 20, 1453-1464.
67. Major, A. S., Dove, D. E., Ishiguro, H., Su, Y. R. et al., Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI((-/-)) mice. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 1790-1795.
68. Kothapalli, D., Fuki, I., Ali, K., Stewart, S. A. et al., Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation. J. Clin. Invest 2004, 113, 609-618.
69. Schafer, C., Heiss, A., Schwarz, A., Westenfeld, R. et al., The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J. Clin. Invest. 2003, 112, 357-366.
70. Merx, M. W., Schafer, C., Westenfeld, R., Brandenburg, V. et al., Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice. J. Am. Soc. Nephrol. 2005, 16, 3357-3364.
71. Stenvinkel, P., Wang, K., Qureshi, A. R., Axelsson, J. et al., Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int. 2005, 67, 2383-2392.
72. Muslin, A. J., Tanner, J. W., Allen, P. M., Shaw, A. S., Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 1996, 84, 889-897.
73. Mayr, M., Chung, Y. L., Mayr, U., Yin, X. et al., Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 2135-2142.